Skip to content

Advertisement

  • Correction
  • Open Access

Correction to: Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trial

  • Hyuk Lee1,
  • Beom Jin Kim2,
  • Sang Gyun Kim3,
  • Jin Il Kim4,
  • Il Ju Choi5,
  • Yong Chan Lee6,
  • Jae G. Kim2Email author,
  • Jae J. Kim1Email author and
  • Korean College of Helicobacter and Upper Gastrointestinal Research
Contributed equally
Trials201718:599

https://doi.org/10.1186/s13063-017-2393-6

Published: 15 December 2017

The original article was published in Trials 2017 18:549

Correction

In the original publication [1] was an error in the grant number in the funding section. The correct version can be found in this Erratum.

Incorrect version:

Funding

This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number HI15C1234).

Correct version:

Funding

This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number HC15C1077).

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Gangnam-gu, South Korea
(2)
Department of Internal Medicine, Chung-Ang University College of Medicine, Dongjak-gu, South Korea
(3)
Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, South Korea
(4)
Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, South Korea
(5)
Center for Gastric Cancer, National Cancer Center Hospital, National Cancer Center, Goyang, South Korea
(6)
Department of Internal Medicine, Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, South Korea

Reference

  1. Lee H. Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trial. Trials. 2017;18:549. doi: 10.1186/s13063-017-2281-0

Copyright

© The Author(s). 2017

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.

Advertisement